Synthetic Genomics Appoints Chief Financial Officer

LA JOLLA, Calif. – – Synthetic Genomics Inc., a privately held company dedicated to developing and commercializing genomic-driven solutions to address global energy and environmental challenges, today announced the appointment of Chuck McBride as Executive Vice President and Chief Financial Officer, effective February 12, 2008. McBride brings more than 30 years of experience in corporate finance and development, investor relations and operations, and has been successful in raising more than a billion dollars in his previous experience. He joins Synthetic Genomics from Capstone Turbine Corporation (NASDAQ: CPST), the world’s leading clean technology manufacturer of microturbine energy systems, where he served as Executive Vice President and Chief Financial Officer. Link.